TELESIS BIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TELESIS BIO and buy or sell other stocks, ETFs, and their options commission-free!About TBIO
Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction.
CEORonald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees—
Employees—
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2011
Founded2011
Employees—
Employees—
TBIO Key Statistics
Market cap2.82B
Market cap2.82B
Price-Earnings ratio74.36
Price-Earnings ratio74.36
Dividend yield—
Dividend yield—
Average volume1.07M
Average volume1.07M
High today$0.021
High today$0.021
Low today$0.021
Low today$0.021
Open price$0.021
Open price$0.021
Volume784.00
Volume784.00
52 Week high$37.99
52 Week high$37.99
52 Week low$0.021
52 Week low$0.021
Stock Snapshot
With a market cap of 2.82B, TELESIS BIO(TBIO) trades at $0.02. The stock has a price-to-earnings ratio of 74.36.
On 2025-12-11, TELESIS BIO(TBIO) stock traded between a low of $0.02 and a high of $0.02. Shares are currently priced at $0.02, which is 0.0% above the low and 0.0% below the high.
The TELESIS BIO(TBIO)'s current trading volume is 784, compared to an average daily volume of 1.07M.
In the last year, TELESIS BIO(TBIO) shares hit a 52-week high of $37.99 and a 52-week low of $0.02.
In the last year, TELESIS BIO(TBIO) shares hit a 52-week high of $37.99 and a 52-week low of $0.02.